 Secondary Prevention
"Secondary Prevention" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The prevention of recurrences or exacerbations of a disease or complications of its therapy.
| Descriptor ID |
D055502
|
| MeSH Number(s) |
E02.897 N02.421.726.825 N06.850.780.750
|
| Concept/Terms |
Secondary Prevention- Secondary Prevention
- Prevention, Secondary
- Preventions, Secondary
- Secondary Preventions
- Secondary Disease Prevention
- Disease Prevention, Secondary
- Disease Preventions, Secondary
- Prevention, Secondary Disease
- Preventions, Secondary Disease
- Secondary Disease Preventions
Relapse Prevention- Relapse Prevention
- Prevention, Relapse
- Preventions, Relapse
- Relapse Preventions
Early Therapy- Early Therapy
- Early Therapies
- Therapies, Early
- Therapy, Early
|
Below are MeSH descriptors whose meaning is more general than "Secondary Prevention".
Below are MeSH descriptors whose meaning is more specific than "Secondary Prevention".
This graph shows the total number of publications written about "Secondary Prevention" by people in this website by year, and whether "Secondary Prevention" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 | | 2000 | 0 | 4 | 4 | | 2001 | 0 | 3 | 3 | | 2002 | 0 | 5 | 5 | | 2003 | 0 | 2 | 2 | | 2004 | 0 | 1 | 1 | | 2005 | 0 | 1 | 1 | | 2006 | 0 | 2 | 2 | | 2007 | 0 | 8 | 8 | | 2008 | 0 | 6 | 6 | | 2009 | 0 | 5 | 5 | | 2010 | 0 | 10 | 10 | | 2011 | 1 | 6 | 7 | | 2012 | 2 | 10 | 12 | | 2013 | 2 | 8 | 10 | | 2014 | 2 | 9 | 11 | | 2015 | 6 | 6 | 12 | | 2016 | 9 | 14 | 23 | | 2017 | 6 | 9 | 15 | | 2018 | 7 | 9 | 16 | | 2019 | 5 | 7 | 12 | | 2020 | 2 | 9 | 11 | | 2021 | 2 | 6 | 8 | | 2022 | 0 | 2 | 2 | | 2023 | 0 | 4 | 4 | | 2024 | 0 | 3 | 3 | | 2025 | 3 | 3 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Secondary Prevention" by people in Profiles.
-
Walker M, Riggs KA, Rohatgi A, Beckman J, Addo T, Girotra S, Bonaca MP, Armstrong E, Kumbhani DJ. Role of Lipids and Lipid Management Therapy Among Patients With Peripheral Artery Disease: A Reappraisal of the Current Evidence and Future Directions. J Am Heart Assoc. 2025 Oct 07; 14(19):e039734.
-
Kapoor E, Sheehan KA, Yu AYX, Kurdyak P, Casaubon LK, Porter J, Fang J, Kapral MK. Association Between Schizophrenia and Adherence to Medications for Secondary Stroke Prevention. Stroke. 2025 Oct; 56(10):3090-3094.
-
Pothula SR, Regueiro M, Click BH. Advancements in the prevention and management of postoperative Crohn's disease recurrence. Expert Rev Gastroenterol Hepatol. 2025 Jul; 19(7):711-723.
-
Warach SJ, Davis LA, Lawrence P, Gajewski B, Wick J, Shi F, Shang TT, Olson DM, Prasad S, Birnbaum L, Richardson JM, Savitz SI, Goldberg MP, Cruz-Flores S, Alba I, Anderson J, Kimmel B, Venkatasubba Rao CP, King B, Dula AN, Milling TJ. Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial. JAMA Neurol. 2025 May 01; 82(5):470-476.
-
Waner EE, Saxon D, Nye HE. Clinical progress note: Secondary fracture prevention. J Hosp Med. 2025 Sep; 20(9):983-987.
-
Canonico ME, Avvedimento M, Piccolo R, Hess CN, Bardi L, Ilardi F, Giugliano G, Franzone A, Gargiulo G, Berkowitz SD, Cannon CP, Esposito G, Bonaca MP. Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndrome: An Updated Review of Current Evidence. Clin Ther. 2025 Jul; 47(7):511-518.
-
Bachour SP, Shah RS, Joseph A, Syed H, Ali AH, Rieder F, Barnes EL, Axelrad J, Holubar SD, Regueiro M, Cohen BL, Click BH. Change in Biologic Class Promotes Endoscopic Remission Following Endoscopic Postoperative Crohn's Disease Recurrence. J Clin Gastroenterol. 2024 Sep 01; 58(8):810-817.
-
Potthast KL, Billups SJ, Fixen DR, Titus O, Saseen JJ, Linnebur SA. Evaluation of Aspirin Prescribing and Gastrointestinal Bleeding in Adults 60 Years of Age and Older in a Large, Academic Health System. Sr Care Pharm. 2024 Jun 01; 39(6):218-227.
-
Gibson CM, Duffy D, Korjian S, Bahit MC, Chi G, Alexander JH, Lincoff AM, Heise M, Tricoci P, Deckelbaum LI, Mears SJ, Nicolau JC, Lopes RD, Merkely B, Lewis BS, Cornel JH, Trebacz J, Parkhomenko A, Libby P, Sacks FM, Povsic TJ, Bonaca M, Goodman SG, Bhatt DL, Tendera M, Steg PG, Ridker PM, Aylward P, Kastelein JJP, Bode C, Mahaffey KW, Nicholls SJ, Pocock SJ, Mehran R, Harrington RA. Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction. N Engl J Med. 2024 05 02; 390(17):1560-1571.
-
Orjuela KD, Leppert MH, Carroll JD. Navigating the Gray: The Complex Story of PFO Closure Utilization. Circ Cardiovasc Qual Outcomes. 2024 01; 17(1):e010581.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|